Debunking CSOs: What Government Contractors and New Entrants Need to Know
Webinar | 04.14.26, 12:00 PM EDT - 1:00 PM EDT
Address
Virtual
Commercial Solutions Openings (CSOs) represent a new and exciting opportunity for some, a disruptive force for others, and one of many strategic tools for more. Our upcoming roundtable discussion with Oliver Wyman, a Marsh business, brings together perspectives so you can gain a clear, practical understanding of what CSOs mean for your pipeline, risk posture, and next bid.
In a fast-moving, roundtable-driven format, Crowell GovCon Strategies President Kate Robb and Oliver Wyman Partner Rachel Jenkins will moderate a panel built for real-world application. Senior Counsel Per Midboe will break down the “watch-outs” that can derail teams: where the gray areas are on competition, what actually triggers protests, and how to avoid giving away too much in IP and data rights terms.
Oliver Wyman Partner Kelleigh Bilms will speak directly to startups and commercial entrants, what agencies want to see as proof of traction, how to present commercialization credibly, and how to protect your upside while still moving quickly. Rachel adds the prime perspective: how CSOs are showing up inside portfolios, how they can disrupt incumbency, and how capture teams should adjust go/no-go decisions, teaming, and pricing when timelines compress.
There will be an additional Q&A section towards the end of the discussion.
For more information, please visit these areas: Government Contracts
Participants

Senior Counsel, Crowell & Moring LLP | Vice President of Growth & Strategy, Crowell GovCon Strategies LLC
- Washington, D.C.
- D | +1.202.624.2697
Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Webinar | 11.17.26

